XTL Biopharmaceuticals logo
XTL Biopharmaceuticals
XTLB | NASDAQ
Chart Builder DCF Calculator
$1.54
-$0.06 (-3.75%)
At close: Nov 16, 2026, 4:00 PM ET
$1.56
+$0.02 (+1.30%)
After-hours: Nov 16, 2026, 7:30 PM ET

XTL Biopharmaceuticals Company Profile

Company profile explained

Company Profile

XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions. Its primary investigational compound, hCDR1, is poised to enter Phase II trials, specifically targeting systemic lupus erythematosus and Sjogren's syndrome. The company holds a crucial licensing agreement with Yeda Research and Development Company Limited, which grants rights for the research, development, and eventual commercialization of hCDR1 across multiple therapeutic indications. Originally established in 1993 as Xenograft Technologies Ltd., the company rebranded to XTL Biopharmaceuticals Ltd. in July 1995. It operates from its headquarters in Ramat Gan, Israel.

Key Executives

Name Position
Noam Band Chief Executive Officer & Director
Segal Niv Chief Financial Officer

Latest SEC Filings

Date Type Title
Oct 14, 2026 6-K Filing
Aug 05, 2026 6-K Filing
Jul 21, 2026 6-K Filing
Jun 30, 2026 20-F Filing
Jun 30, 2026 6-K Filing
Jun 29, 2026 6-K Filing
Jun 23, 2026 6-K Filing
May 22, 2026 6-K Filing
May 15, 2026 6-K Filing
May 07, 2026 6-K Filing
View All SEC Filings ➞
XTL Biopharmaceuticals
XTL Biopharmaceuticals logo
Country Israel
IPO Date Sep 1, 2005
Industry Biotechnology
Sector Healthcare
Employees 10
CEO Noam Band

Contact Details

85 Medinat Hayehudim St. Herzliya, TA 4676670 Israel

Stock Details

Ticker Symbol XTLB
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001023549
CUSIP Number 98386D406
ISIN Number US98386D4060
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.